ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics defeated an appeal by Myriad Genetics to block competing DNA-based tests to determine hereditary risk for breast and ovarian cancer after a ...

Just weeks after it lost at the high court, Myriad filed new lawsuits against the first two competitors who began offering BRCA gene testing, Ambry Genetics and Gene by Gene. Despite its Supreme ...

New study published in Genetics in Medicine reveals transformative impact of Ambry's Patient for Life reanalysis program.

ALISO VIEJO – Charles Dunlop, founder and CEO of Ambry Genetics, never tested his own DNA even though he had the technology at his fingertips. He refused to displace a vial of a patient’s ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a leader in clinical diagnostic testing and a subsidiary of REALM IDx, Inc., announced today the findings of a study that showed paired RNA ...

Konica Minolta has agreed to acquire Ambry Genetics for up to $1 billion, the companies said on July 5, 2017, in a deal the buyer envisions as the first step in its strategy of developing a ...

Tempus AI delivered strong Q1 results, driven by the Ambry Genetics acquisition and a major AstraZeneca contract, boosting ...

Shares of Tempus AI TEM gained 18.4% after it announced an agreement, on Nov. 4, 2024, to acquire Ambry Genetics for $600 ...

Aliso Viejo-based Ambry Genetics Corp. on Nov. 4 announced an agreement to be acquired for $600 million by Tempus AI Inc. “They’ve achieved one of the rare things in our space where you actually have ...

Hence, in 2017, the Tokyo-based company bought Ambry Genetics, an Aliso Viejo-based testing firm, for about $1 billion. “He walked me through his vision of creating this integrated diagnostics company ...

Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), announced the publication of a study in Genetics in Medicine, the official journal of the American College of Medical ...